| row-start col-md-7 #top-section top-section new-section |
Exporting Healthcare & Life Sciences to China
Thursday, 25 February 2021 10:00 am to 11:15 am
Online
Join key officials from the Department for International Trade (DIT) South West, the China-Britain Business Council (CBBC), NJ Akers & Co and Cisema for a comprehensive look at China’s digital healthcare and medical devices market in 2021.
Register Your Place Now - Click Here
What will I learn?
This webinar is suitable for both new and existing exporters to China and will cover steps to start or further expand presence in the Chinese market. Both the legal and regulatory environments will also be discussed, ensuring attendees receive the most relevant updates on market conditions.
Please scroll down the page to see the list of speakers.
Who is this event for?
This webinar is for South West medical device and digital health solution providers.
Unfortunately we are unable to accept bookings out of the South West area or booking from service providers/intermediaries.
Register Your Place Now - Click Here
Why China?
China’s healthcare market is the second largest in the world and continues to receive ever increasing levels of private and public sector investment. The sector does face a wide range of challenges: ongoing urban and rural disparity; an ageing population and the rising burden of non-communicable diseases. These difficulties, in line with continued improvement of living standards and rising household disposable income, provide opportunities for UK companies seeking to grow their export business in the Chinese market.
The Chinese government is firmly committed to healthcare development as evidenced by the Healthy China 2030 planning outline, demonstrating an ever-liberalising approach to market and regulatory access.
The Chinese market is far from a quick win, but for companies that consult with the right partners, the rewards can be great. Drawing on trade experts at the Department for International Trade, China-Britain Business Council, legal advisors NJ Akers and regulatory specialists Cisema, this webinar is suitable for companies within the medical devices and digital health fields.
Opportunities in these areas are there to be seized; nearly 50% of China’s $52 billion medical device market is accounted for by imports and with a continued strategy centred on digital solutions to both relieve existing challenges and provide a more stable and accessible healthcare model, the timing has never been more optimal for South West companies to look at this exciting market.
Register Your Place Now - Click Here
Please Note: We will send you details of the online platform and login details prior to the event.
This event is organised in association with the Western Gateway Partnership.
Business West (delivery partner for the Department for International Trade) is committed to providing a professional, friendly, safe and welcoming environment for all participants at its events. Inappropriate behaviour on video, audio & chat facilities will not be tolerated during any portion of a meeting or event. It will be at the sole discretion of the host/facilitator to immediately expel any participants from the event if their behaviour is deemed to be inappropriate and/or offensive.
Privacy Policy
We take your data very seriously and are committed to the privacy and security of it. This event is organised by Business West, delivery partner for The Department of International Trade for the SW, their privacy policies are available at DIT Personal Information Charter.
| row-end col-sm-12 col-md-5 |
| row-start col-xs-12 colour-section row-end |
Speakers
Jamie Shaw, Healthcare Life Science Sector Specialist at DIT - Western Gateway
Jamie comes with significant private sector experience where most recently he was based overseas as an International Account Manager for China’s largest medical device manufacturer, Mindray. Jamie worked with overseas subsidiaries within the business and supported/implemented new direct/indirect sales channels in a number of territories; working with both public and private sector healthcare institutions.
Mark Hedley, Director - Knowledge Economy at the CBBC
A fluent Mandarin speaker, Mark has spent 15 years travelling to and living in China, including 6 years permanently based in China. Prior to joining CBBC, Mark worked for B2B International, a leading market research consultancy specializing in business-to-business research for clients in the technology and healthcare sectors. He was previously based in Shanghai, were he worked for an Asia market access consultancy, helping Western technology firms with China market entry and business development initiatives. A fluent Mandarin speaker, Mark holds a Masters in Chinese Business from Sheffield University and MBA from Lancaster University.
Graeme McCallum, Patent & Trade Mark Attorney at NJ Akers & Co
Graeme McCallum is a qualified UK and European patent attorney and trade mark attorney and an IP Litigator. He has over 20 years experience helping clients to protect and enforce their intellectual property rights.
Graeme has a broad range of experience in different medical related technologies, including surgical instruments, stents and grafts, catheters, NMR imaging, drug delivery systems and anti-bacterial compositions as well as more general healthcare technologies such as monitors, beds and mattresses.
Graeme has substantial experience of assisting start-ups and SMEs, as well as managing the IP portfolios of multi-national corporations. He assists clients to extract maximum value from their innovations and to ensure that their IP strategies are aligned with their business strategies and work to support the business. He has particular expertise in advising clients on brand protection and on high value and standards related patent cases.
Hamish King, RAC, LLB, Chief Operating Officer at Cisema
Hamish King is a lawyer by training (formerly with Linklaters in Hong Kong) and supports companies with difficult regulatory affairs queries for China. He regularly writes articles on China market access and regulatory pathways. Currently residing in Hong Kong and specialising in NMPA registration of medical devices, Hamish has a close interest in the regulatory implications of digital healthcare and AI applications.
